CureVac N.V.

NASDAQ: CVAC · Real-Time Price · USD
3.60
0.18 (5.11%)
At close: May 16, 2025, 10:22 AM

CureVac Revenue Breakdown

Period Ending Dec 31, 2023 Dec 31, 2022
Product Revenue 11.39M 19.57M
Product Revenue Growth -41.78% n/a
Research and development services Revenue 11.31M n/a
Research and development services Revenue Growth n/a n/a

Operating Expense Breakdown

Period Ending Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Mar 31, 2019
Selling, General, and Administrative Revenue 16.34M 14.24M 13.45M 16.8M 23.25M 15.98M 19.07M 19.7M 23.66M 22.08M 23.07M 20.6M 14.61M 22.66M 31.78M 19.9M 11.81M 9.22M 14.66M 10.07M 14.95M 9.1M 5.67M
Selling, General, and Administrative Revenue Growth +14.75% +5.87% -19.95% -27.75% +45.50% -16.19% -3.23% -16.73% +7.18% -4.30% +12.00% +41.03% -35.54% -28.71% +59.71% +68.55% +28.02% -37.09% +45.52% -32.61% +64.27% +60.52% n/a
Research and Development Revenue 44.14M 49.98M 31.09M 27.82M 29.37M 27.25M 30.87M 24.25M 27.62M 12.51M 11.64M 10.79M 531.18M 48.46M 131.28M 104.99M 37.47M 34.57M 30.87M 10.9M 12.58M 5.35M 10.86M
Research and Development Revenue Growth -11.69% +60.74% +11.74% -5.27% +7.81% -11.74% +27.29% -12.18% +120.72% +7.53% +7.88% -97.97% +996.10% -63.09% +25.05% +180.18% +8.39% +12.00% +183.12% -13.32% +135.13% -50.75% n/a
Sales and Marketing Revenue 4.09M 174K 75K 105K 82K 145K 88K 108K 97K 93K -44K 271K 511K 203K 552K 477K -76K -200K 679K 330K 1.27M -24K 198K
Sales and Marketing Revenue Growth +2252.30% +132.00% -28.57% +28.05% -43.45% +64.77% -18.52% +11.34% +4.30% -311.36% -116.24% -46.97% +151.72% -63.22% +15.72% -727.63% -62.00% -129.46% +105.76% -74.02% -5391.67% -112.12% n/a